Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 5:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 354 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Treatment Decisions Clear all

Conditions: Immune Thrombocytopenia
Interventions: Second Line ITP agents; Drug
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 1 Year to 18 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 26
States / cities: Little Rock, Arkansas • Los Angeles, California • Oakland, California + 22 more

Conditions: Carcinoma, Hepatocellular
Interventions: Any treatment for unresectable HCC as chosen by the physician; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 24
States / cities: Multiple Locations, Arkansas • Multiple Locations, California • Multiple Locations, Colorado + 21 more

Conditions: Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
Interventions: counseling intervention, study of socioeconomic and demographic variables, management of therapy complications, psychosocial assessment and care; Other · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 6
States / cities: Ann Arbor, Michigan • New York, New York

Conditions: HIV Infections, Substance Abuse
Interventions: Decision aid, Standard care; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Aortic Valve Stenosis
Interventions: "Treatment Choices for Aortic Stenosis" Decision Aid; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 85 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Aurora, Colorado • Boston, Massachusetts

Conditions: Latent Tuberculosis
Interventions: CDC/NTCA guidelines only, LTBI ASSIST and CDC/NTCA guidelines only; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Standard Treatment Versus Engagement Focused Treatment
Interventions: Engagement focused care, Standard Care; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 465 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Carcinoma, Hepatocellular
Interventions: Sorafenib (Nexavar, BAY43-9006); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 3,371 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 37
States / cities: Many Locations, Alabama • Many Locations, Arizona • Many Locations, Arkansas + 34 more

Conditions: Advanced Cancer
Interventions: Communication; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: HIV
Interventions: FAmily-CEntered Advance Care Planning, Healthy Living Control; Behavioral
Lead sponsor: Children's National Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 444 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 5
States / cities: Washington D.C., District of Columbia

Conditions: Premature Birth
Interventions: Order of pictographs provided to participants, Level of description in survival pictograph; Behavioral
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 839 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Smoking, Cigarette, Smoking Cessation
Interventions: Smoking Cessation iPad Decision Aid Tool; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 100 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Cerebral Aneurysm
Interventions: Option grid for cerebral aneurysm treatment, Control; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Cancer
Interventions: FAmily CEntered Advance Care Planning for Teens with Cancer; Behavioral
Lead sponsor: Maureen Lyon; Other
Eligibility: 14 Years to 99 Years
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Minneapolis, Minnesota • Akron, Ohio + 1 more

Conditions: Mental Illness, Shared Decision Making
Interventions: Coaching and Virtual Provider Program Practice; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Population Health Management, Patient Navigation
Interventions: AI-Supported Rising-Risk Care Navigation; Other
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 9,906 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Menopause
Interventions: Personalized risk assessment, genetic counseling intervention; Procedure
Lead sponsor: Yale University; Other
Eligibility: 40 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2004
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Healthy Subject, Stage 0 Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
Interventions: Biospecimen Collection, Functional Magnetic Resonance Imaging, Questionnaire Administration; Procedure · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 178 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Acute Appendicitis
Interventions: Patients with acute appendicitis; Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Prostate Cancer
Interventions: Decipher; Other
Lead sponsor: GenomeDx Biosciences Corp; Industry
Eligibility: Male only
Enrollment: 286 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 19
States / cities: Anchorage, Alaska • Los Angeles, California • Aurora, Colorado + 15 more

Conditions: Prostate Cancer, Advanced Prostate Carcinoma
Interventions: Participant Surveys, Mobile app; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Heart Failure, Diabetes Mellitus, Type 2
Interventions: On-screen electronic alert; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,524 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Prostate Cancer
Interventions: Prolaris; Behavioral
Lead sponsor: Myriad Genetic Laboratories, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 1,511 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 12
States / cities: San Diego, California • West Haven, Connecticut • Tampa, Florida + 9 more

Conditions: Healthy Men Age 50 Who Are Considering PSA Screening
Interventions: DESI for home viewing, DESI for viewing at Shared Medical Appointment, Option of SMA and DESI or DESI only; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years to 75 Years · Male only
Enrollment: 2,521 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Palo Alto, California • Chapel Hill, North Carolina

Search by objective public record fields.

ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP

GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start

Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women

OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings

Impact of a Patient Decision Aid for Treatment of Aortic Stenosis

Clinical Practice Guidelines Versus Decision-support for Latent Tuberculosis Infection (LTBI) Management

Improving Transitional Care Experiences in Mental Health

Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib

Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shared Decision Making for Third-line or Beyond Palliative Systemic Therapy

Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care

Order Effects of Prematurity Outcome Data

Feasibility of a Decision Aid for E-Cigarettes in Primary Care

Decision Aids in Cerebral Aneurysm Treatment

Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer

Goal Elicitation, Treatment Prioritization, & Electronically-Practiced Discussion for Psychiatry

AI-Supported Care Engagement for Next-step Delivery - Medicare Advantage

Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer

Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer

Appendicitis Choice of Treatment Study

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer

Electronic Alerts for Heart Failure Prevention in Diabetes

Prospective Prolaris Value and Efficacy

Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1